Amarin | AMRN - PE Price to Earnings

Stock Price
13.97
Daily Change
-1.55 -9.99%
Monthly
-10.16%
Yearly
20.81%
Q1 Forecast
15.11

Amarin reported $91.05 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin USD 91.05 88.3 Jun/2023
AstraZeneca USD 27.29 5.8 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Halozyme Therapeutics USD 23.16 7.7 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novartis USD 15.74 0.15 Sep/2025